Terms: = Skin cancer AND PMS1, hPMS1, 5378, ENSG00000064933, PMSL1, HNPCC3, DKFZp781M0253
13 results:
1. Early switch from run-in treatment with vemurafenib plus cobimetinib to atezolizumab after 3 months leads to rapid loss of tumour control in patients with advanced BRAFV600-positive melanoma: The ImmunoCobiVem phase 2 randomised trial.
Livingstone E; Gogas H; Kandolf-Sekulovic L; Meier F; Eigentler TK; Ziemer M; Terheyden PAM; Gesierich AH; Herbst RA; Kähler KC; Ziogas DC; Mijuskovic Z; Garzarolli M; Garbe C; Roesch A; Ugurel S; Gutzmer R; Grob JJ; Kiecker F; Utikal J; Windemuth-Kieselbach C; Eckhardt S; Zimmer L; Schadendorf D
Eur J Cancer; 2023 Sep; 190():112941. PubMed ID: 37482012
[TBL] [Abstract] [Full Text] [Related]
2. Deficient mismatch repair is detected in large-to-giant congenital melanocytic naevi: providing new insight into aetiology and diagnosis.
Wei B; Gu J; Gao B; Bao Y; Duan R; Li Q; Xie F
Br J Dermatol; 2023 Jan; 188(1):64-74. PubMed ID: 36689509
[TBL] [Abstract] [Full Text] [Related]
3. Microsatellite Instability Predicts Response to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Roncati L
Acta Dermatovenerol Croat; 2018 Dec; 26(4):341-343. PubMed ID: 30665488
[TBL] [Abstract] [Full Text] [Related]
4. Gastrointestinal Behcet's-like disease with myelodysplastic neoplasms with trisomy 8: a French case series and literature review.
Wesner N; Drevon L; Guedon A; Fraison JB; Terrier B; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Seksik P; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
Leuk Lymphoma; 2019 Jul; 60(7):1782-1788. PubMed ID: 30457024
[TBL] [Abstract] [Full Text] [Related]
5. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
[TBL] [Abstract] [Full Text] [Related]
6. Association of common variants in mismatch repair genes and breast cancer susceptibility: a multigene study.
Conde J; Silva SN; Azevedo AP; Teixeira V; Pina JE; Rueff J; Gaspar JF
BMC Cancer; 2009 Sep; 9():344. PubMed ID: 19781088
[TBL] [Abstract] [Full Text] [Related]
7. Altered expression and new mutations in DNA mismatch repair genes MLH1 and MSH2 in melanoma brain metastases.
Korabiowska M; König F; Verheggen R; Schlott T; Cordon-Cardo C; Romeike B; Brinck U
Anticancer Res; 2004; 24(2B):981-6. PubMed ID: 15161053
[TBL] [Abstract] [Full Text] [Related]
8. Relationship between DNA mismatch repair genes expression, Ku-genes expression and ploidy-related parameters in the progression of pigmented lesions of the skin.
Korabiowska M; Tscherny M; Stachura J; Ruschenburg I; Cordon-Cardo C; Brinck U
In Vivo; 2002; 16(5):317-21. PubMed ID: 12494870
[TBL] [Abstract] [Full Text] [Related]
9. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract] [Full Text] [Related]
10. Comparative study of the expression of DNA mismatch repair genes, the adenomatous polyposis coli gene and growth arrest DNA damage genes in melanoma recurrences and metastases.
Korabiowska M; Brinck U; Kotthaus I; Berger H; Droese M
Melanoma Res; 2000 Dec; 10(6):537-44. PubMed ID: 11198475
[TBL] [Abstract] [Full Text] [Related]
11. Loss of DNA-mismatch repair gene expression in oral melanomas.
Korabiowska M; Brinck U; Ruschenburg I; Honig JF; Stachura J; Droese M
Oncol Rep; 1999; 6(4):921-3. PubMed ID: 10373682
[TBL] [Abstract] [Full Text] [Related]
12. Expression of five selected human mismatch repair genes simultaneously detected in normal and cancer cell lines by a nonradioactive multiplex reverse transcription-polymerase chain reaction.
Wei Q; Guan Y; Cheng L; Radinsky R; Bar-Eli M; Tsan R; Li L; Legerski RJ
Pathobiology; 1997; 65(6):293-300. PubMed ID: 9491849
[TBL] [Abstract] [Full Text] [Related]
13. Increased labeling of human melanoma cells in vitro using combinations of monoclonal antibodies recognizing separate cell surface antigenic determinants.
Krizan Z; Murray JL; Hersh EM; Rosenblum MG; Glenn HJ; Gschwind CR; Carlo DJ
Cancer Res; 1985 Oct; 45(10):4904-9. PubMed ID: 2411391
[TBL] [Abstract] [Full Text] [Related]